Master protocols present systematic path forward for evaluating COVID-19 treatments
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
The globe is now scattered with small, investigator-led studies of COVID-19 candidate therapies, with no systematic way for regulators to determine which are safest and most beneficial. Master protocol trials can solve that problem